PT86776B - Processo para a preparacao de acido piperazinocarboxilico e de composicoes farmaceuticas que o contem - Google Patents

Processo para a preparacao de acido piperazinocarboxilico e de composicoes farmaceuticas que o contem Download PDF

Info

Publication number
PT86776B
PT86776B PT86776A PT8677688A PT86776B PT 86776 B PT86776 B PT 86776B PT 86776 A PT86776 A PT 86776A PT 8677688 A PT8677688 A PT 8677688A PT 86776 B PT86776 B PT 86776B
Authority
PT
Portugal
Prior art keywords
compound
formula
treatment
preparation
salt
Prior art date
Application number
PT86776A
Other languages
English (en)
Portuguese (pt)
Other versions
PT86776A (pt
Inventor
Bernhard Aebischer
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT86776A publication Critical patent/PT86776A/pt
Publication of PT86776B publication Critical patent/PT86776B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT86776A 1987-02-18 1988-02-17 Processo para a preparacao de acido piperazinocarboxilico e de composicoes farmaceuticas que o contem PT86776B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (2)

Publication Number Publication Date
PT86776A PT86776A (pt) 1988-03-01
PT86776B true PT86776B (pt) 1992-05-29

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86776A PT86776B (pt) 1987-02-18 1988-02-17 Processo para a preparacao de acido piperazinocarboxilico e de composicoes farmaceuticas que o contem

Country Status (28)

Country Link
JP (1) JPH0723387B2 (enrdf_load_html_response)
KR (1) KR960015190B1 (enrdf_load_html_response)
AT (1) AT391320B (enrdf_load_html_response)
AU (1) AU613009B2 (enrdf_load_html_response)
BE (1) BE1002427A3 (enrdf_load_html_response)
CA (1) CA1327799C (enrdf_load_html_response)
CH (1) CH675125A5 (enrdf_load_html_response)
CY (1) CY1739A (enrdf_load_html_response)
DE (1) DE3804936C2 (enrdf_load_html_response)
DK (1) DK168441B1 (enrdf_load_html_response)
ES (2) ES2011319A6 (enrdf_load_html_response)
FI (1) FI86733C (enrdf_load_html_response)
FR (1) FR2610932B1 (enrdf_load_html_response)
GB (2) GB8703749D0 (enrdf_load_html_response)
GR (1) GR1002471B (enrdf_load_html_response)
HK (1) HK142093A (enrdf_load_html_response)
HU (2) HU199858B (enrdf_load_html_response)
IE (1) IE59098B1 (enrdf_load_html_response)
IL (1) IL85436A0 (enrdf_load_html_response)
IT (1) IT1219447B (enrdf_load_html_response)
LU (1) LU87129A1 (enrdf_load_html_response)
MY (1) MY103206A (enrdf_load_html_response)
NL (1) NL8800412A (enrdf_load_html_response)
NZ (1) NZ223529A (enrdf_load_html_response)
PH (1) PH25512A (enrdf_load_html_response)
PT (1) PT86776B (enrdf_load_html_response)
SE (1) SE467256B (enrdf_load_html_response)
ZA (1) ZA881146B (enrdf_load_html_response)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
EP0826032A1 (de) * 1995-05-08 1998-03-04 Lonza Ag Biotechnologisches verfahren zur herstellung von r-alpha-piperazincarbonsäure und s-alpha-piperazincarbonsäureamid
WO1998051298A1 (en) 1997-05-12 1998-11-19 Ortho-Mcneil Pharmaceutical Inc. Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Also Published As

Publication number Publication date
JPS63203691A (ja) 1988-08-23
ES2011319A6 (es) 1990-01-01
IT8847631A0 (it) 1988-02-12
HU199858B (en) 1990-03-28
PT86776A (pt) 1988-03-01
DK79688D0 (da) 1988-02-16
GB8803438D0 (en) 1988-03-16
KR880009944A (ko) 1988-10-06
FI880744L (fi) 1988-08-19
CY1739A (en) 1995-10-20
GR880100084A (el) 1988-12-16
DK168441B1 (da) 1994-03-28
FI880744A0 (fi) 1988-02-17
GB2201676A (en) 1988-09-07
ES2021904A6 (es) 1991-11-16
DE3804936A1 (de) 1988-09-01
AU1175888A (en) 1988-08-25
ATA36788A (de) 1990-03-15
NL8800412A (nl) 1988-09-16
HUT49361A (en) 1989-09-28
PH25512A (en) 1991-07-24
LU87129A1 (fr) 1988-09-20
IL85436A (enrdf_load_html_response) 1992-12-01
KR960015190B1 (ko) 1996-11-01
CH675125A5 (enrdf_load_html_response) 1990-08-31
GR1002471B (el) 1996-11-15
GB2201676B (en) 1991-01-02
IT1219447B (it) 1990-05-18
SE8800541D0 (sv) 1988-02-17
BE1002427A3 (fr) 1991-02-05
FR2610932A1 (fr) 1988-08-19
FR2610932B1 (fr) 1990-11-16
AU613009B2 (en) 1991-07-25
GB8703749D0 (en) 1987-03-25
ZA881146B (en) 1989-10-25
FI86733B (fi) 1992-06-30
AT391320B (de) 1990-09-25
HU211269A9 (en) 1995-11-28
SE467256B (sv) 1992-06-22
JPH0723387B2 (ja) 1995-03-15
DE3804936C2 (de) 1997-02-13
DK79688A (da) 1988-08-19
IE880413L (en) 1988-08-18
MY103206A (en) 1993-05-29
CA1327799C (en) 1994-03-15
NZ223529A (en) 1991-02-26
FI86733C (fi) 1992-10-12
IL85436A0 (en) 1988-07-31
IE59098B1 (en) 1994-01-12
HK142093A (en) 1994-01-07

Similar Documents

Publication Publication Date Title
AU2014340182B2 (en) Cromolyn derivatives and related methods of imaging and treatment
US8617517B2 (en) Cromolyn derivatives and related methods of imaging and treatment
PT723546E (pt) Blocos primitivos de 1,2,4-triazolo(1,5-a) e a sua utilizacao no tratamento de desordens neurologicas
JP2010505747A (ja) Ａ２ａアデノシンレセプタの選択的アンタゴニスト
PT86776B (pt) Processo para a preparacao de acido piperazinocarboxilico e de composicoes farmaceuticas que o contem
EP3164402A1 (en) N-substituted noribogaine prodrugs
EA009767B1 (ru) Производные пролина, обладающие сродством к альфа-2-дельта субъединице кальциевого канала
JP2025514548A (ja) カレバスチンの塩及びその用途
PT87854B (pt) Processo para a preparacao de derivados de tio-ureia
PT736020E (pt) Compostos 6-(2-imidazolinilamino)quinolina uteis como alfa-2 adrenoceptor agonistas
CN117561254A (zh) 用于肺癌治疗的嘧啶基氨基苯
KR20190110106A (ko) 신경퇴행성 질환의 치료를 위한 중성 스핑고미엘리나제 2(nSMAse2)의 저분자 억제제
CN118678954A (zh) 作为kv7通道激活剂的吡唑基化合物
RU2566757C2 (ru) Арилфторфосфатные ингибиторы кишечного апикального мембранного натрий/фосфатного котранспорта
JP4781362B2 (ja) ４級アンモニウム基を有するキヌクリジン化合物とその調製方法、およびアセチルコリン遮断剤としての用途
CN114685472B (zh) 多取代的尿嘧啶衍生物及其用途
CN116217567B (zh) 烃基取代的α-咔啉类似物或其药用盐、其药物组合物及其制备方法和用途
CS221846B2 (en) Method of making the ethanolamine derivatives
HK40017498A (en) Cromolyn derivatives and related methods of imaging and treatment
CN117500506A (zh) Atr抑制剂与parp抑制剂的组合用于治疗癌症的用途
CN108069833A (zh) 苯并四环衍生物及其制备方法和在医药上的应用
SI8111704A8 (sl) Postopek za pripravo etanolaminskih derivatov
BR112018002245B1 (pt) Composto amida selecionado do ácido ?-hidroxybutírico, processo para a preparação do referido composto, uso do referido composto e composição farmacêutica compreendendo o referido composto
HK1164286A (en) Cromolyn derivatives and related methods of imaging and treatment
HK1164286B (en) Cromolyn derivatives and related methods of imaging and treatment

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911125

PC3A Transfer or assignment

Free format text: 971017 NOVARTIS AG CH

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20030531